Cefazolin inoculum effect among methicillinsusceptible Staphylococcus aureus isolated from patients with skin infections
Open Access
- 1 January 2021
- journal article
- Published by Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy in Clinical Microbiology and Antimicrobial Chemotherapy
- Vol. 23 (2)
- https://doi.org/10.36488/cmac.2021.2.205-211
Abstract
Objective. To evaluate frequency and intensity of cefazolin inoculum effect among methicillin-susceptible staphylococci isolated from patients with skin infections. Materials and Methods. A total of 80 methicillin susceptible isolates of Staphylococcus aureus were identified by cefoxitin disk-diffusion test and negative results of real-time PCR for mecA gene. Inoculum effect was measured by broth microdilution test with two inocula with concentrations of 5 × 105 CFU/mL and 5 × 107 CFU/mL. The disk-diffusion test with cefoxitin was also performed. Penicillin susceptibility was determined by disk-diffusion method. Beta-lactamase blaZ gene was identified by real-time PCR. Results. The frequency of cefazolin inoculum effect in tested isolates was 30% which is consistent with data from different countries. The MIC values for concentrated inoculum reached CLSI breakpoint for cefazolin resistance in 2.5% of isolates. The isolates with inoculum effect and those without it had the similar MIC values for cefazolin in broth microdilution test for standard inocula and similar diameters of inhibition zone in disk-diffusion test with cefazolin. Penicillin resistance was more frequent in inoculum effect-positive isolates. Beta-lactamase activity is considered as a main cause of cefazolin inoculum effect in staphylococci. The beta-lactamase blaZ gene was identified in the majority of isolates with cefazolin inoculum effect, but it was also prevalent among inoculum effect-negative isolates. Conclusions. Up to 30% of MSSA isolates from skin lesions in dermatological patients from SaintPetersburg are positive for cefazolin inoculum effect. Those isolates are usually characterized by penicillin resistance. Most of the cefazolin inoculum effect-positive isolates also carry beta-lactamase blaZ gene.Keywords
This publication has 22 references indexed in Scilit:
- Association between Type A blaZ Gene Polymorphism and Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2016
- Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohortEuropean Journal of Clinical Microbiology & Infectious Diseases, 2016
- Phenotypic antimicrobial susceptibility and occurrence of selected resistance genes in gram-positive mastitis pathogens isolated from Wisconsin dairy cowsJournal of Dairy Science, 2015
- Characterisation of β-lactam resistance mediated by blaZ in staphylococci recovered from captive and free-ranging wallabiesJournal of Global Antimicrobial Resistance, 2015
- Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcomeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Real-Time PCR Assay for Detection of blaZ Genes in Staphylococcus aureus Clinical IsolatesJournal of Clinical Microbiology, 2014
- Prevalence of blaZ Gene Types and the Inoculum Effect with Cefazolin among Bloodstream Isolates of Methicillin-Susceptible Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2012
- Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus : Frequency and Possible Cause of Cefazolin Treatment FailureAntimicrobial Agents and Chemotherapy, 2009
- Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococciJournal of Antimicrobial Chemotherapy, 2006
- Characterization of a Chromosomal Gene Encoding Type B β-Lactamase in Phage Group II Isolates of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1998